We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Magnolia Draws Warning Letter for Inadequate Testing, CAPA Issues
Magnolia Draws Warning Letter for Inadequate Testing, CAPA Issues
Magnolia Medical Technologies, developer of the Steripath Gen 2 blood collection system, drew a warning letter from the FDA for qualify failures observed during a June 3 to July 15 inspection of its Seattle premises.